PharmaBlock Sciences (Nanjing) Dividends and Buybacks
Dividend criteria checks 3/6
PharmaBlock Sciences (Nanjing) is a dividend paying company with a current yield of 0.9% that is well covered by earnings.
Key information
0.9%
Dividend yield
0.3%
Buyback Yield
| Total Shareholder Yield | 1.2% |
| Future Dividend Yield | 0.4% |
| Dividend Growth | 30.3% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.310 |
| Payout ratio | 35% |
Recent dividend and buyback updates
Recent updates
PharmaBlock Sciences (Nanjing) (SZSE:300725) Takes On Some Risk With Its Use Of Debt
Nov 22
PharmaBlock Sciences (Nanjing), Inc.'s (SZSE:300725) P/E Is Still On The Mark Following 40% Share Price Bounce
Sep 30PharmaBlock Sciences (Nanjing)'s (SZSE:300725) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Aug 23We Think PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Taking Some Risk With Its Debt
Jul 31PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Increasing Its Dividend To CN¥0.31
Jun 12PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely
Apr 21PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Looks Just Right With A 25% Price Jump
Mar 07Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300725 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 300725's dividend payments have increased, but the company has only paid a dividend for 7 years.
Dividend Yield vs Market
| PharmaBlock Sciences (Nanjing) Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300725) | 0.9% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Pharmaceuticals) | 1.7% |
| Analyst forecast (300725) (up to 3 years) | 0.4% |
Notable Dividend: 300725's dividend (0.9%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 300725's dividend (0.9%) is low compared to the top 25% of dividend payers in the CN market (2.15%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (35.2%), 300725's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (32%), 300725's dividend payments are well covered by cash flows.